No Direct Evidence Available for Either Product
The provided evidence does not contain any studies, guidelines, or drug labels specifically comparing or evaluating Belotero Revive or Luhilo for pigmentation and large pores. The drug label evidence 1 pertains to HULIO (adalimumab), a TNF blocker for inflammatory conditions—completely unrelated to cosmetic dermal fillers.
What the Evidence Actually Shows
The available research addresses hyaluronic acid-based skin boosters in general, but without specific data on your two products:
Belotero Revive (CPM-HA20G)
- One comparative study exists 2: A 2022 split-face trial compared Belotero Revive (CPM-HA20G) with Profhilo (HCC) in 24 healthy females
- Results showed: Both products improved hydration, elasticity, TEWL, and melanin equally with no significant differences between them
- Specific to your question: CPM-HA20G showed significant improvement in water content, but the study did not specifically measure pore size reduction or pigmentation as primary outcomes
- High patient satisfaction with mild, transient side effects
Luhilo
- Zero published evidence in the provided materials
- No studies, no drug label, no safety data, no efficacy data for pigmentation or pores
Clinical Reasoning Based on Available Evidence
For pigmentation improvement: The 2025 guidelines 3 discuss autologous platelet concentrates (APCs) for melasma with significant mMASI score reductions, but these are not relevant to comparing commercial HA fillers.
For pore reduction: Multiple studies 4, 5 demonstrate that low molecular weight HA intradermal injections can reduce pore size by approximately 40%, but none specifically tested either Belotero Revive or Luhilo.
The Bottom Line
Based on the single available comparative study 2, Belotero Revive demonstrates documented safety and efficacy for skin quality improvement with high patient satisfaction. In contrast, Luhilo has no published evidence in the provided materials to support its use for any indication.
Practical Algorithm:
- If choosing between these two products: Select Belotero Revive due to published evidence of safety and efficacy
- For pigmentation: Consider combining with topical agents (hydroquinone, tretinoin, tranexamic acid) as suggested in guidelines 3
- For pores: Intradermal HA injections (20 mg/mL concentration) show 40% improvement rates 4
- Treatment protocol: 3 sessions spaced 2-4 weeks apart based on general HA booster evidence 6, 7
Critical Caveat:
The absence of head-to-head data or specific studies on Luhilo's formulation (dual-weight HA with amino acids, peptides, niacinamide, and arbutin) means any recommendation is based on limited evidence for one product and zero evidence for the other—not on comparative superiority for your specific indications.